Allogeneic Umbilical Cord MSCs for Liver Cirrhosis: Phase I Trial Results and Hepatic Artery Delivery
A 2026 Phase I trial shows umbilical cord stem cells delivered directly to the liver can reverse cirrhosis markers.
Read More »Cell La Vie Blog
Leading stem cell and exosome therapy research blog by Cell La Vie, Bangkok. Clinical insights, cost breakdowns, and regenerative treatment guides.